Mayo Clinic
Rochester, Minnesota, 55905, United States
Location contact
Ashley Clinical Research Coordinator
CONTACT
David T Jones, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07014982
The RADiaNT study investigates whether guided meditation, using the Muse™ headband and biofeedback app, can improve sleep, mood, and cognitive performance, aiming to assess its impact on mental and emotional well-being.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Rochester, Minnesota, 55905, United States
Ashley Clinical Research Coordinator
CONTACT
David T Jones, MD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants who complete guided meditation will be asked to meditate for 5 minutes a day, five times a week for two 6-week periods.
Time frame: 17 weeks
Total duration of sleep time spent in slow wave sleep (delta), reported in minutes
Time frame: 17 weeks
Proportion is the percentage of sleep time spent in slow wave sleep (delta)
Time frame: 17 weeks
Investigators will ask patients to answer the PSS questionnaire at the beginning, interim, and end of the study to see if there were any improvements in sleep quality over the intervention periods. This questionnaire is on a scale that scores 0-40, with the higher the score being a higher level of stress.
Time frame: 17 weeks
The Patient Health Questionnaire 9-item (PHQ-9) scale used to assess severity of depression. Scoring is calculated by assigning scores of 0, 1, 2, and 3 to the response categories, respectively, of "not at all," "several days," "more than half the days," and "nearly every day." Total score ranges from 0 to 27 where 0 is no depression, 1-4 is minimal depression, 5-9 is mild depression, 10-14 is moderate depression, and 15-19 is moderately severe depression and 20-27 severe depression.
Time frame: 17 weeks
The General Anxiety Disorder 7-item (GAD 7) scale to assess severity of generalized anxiety disorder. Scoring is calculated by assigning scores of 0, 1, 2, and 3 to the response categories, respectively, of "not at all," "several days," "more than half the days," and "nearly every day." Total score for the seven items ranges from 0 to 21 where 0 is no anxiety, 1-4 is minimal anxiety, 5-9 is mild anxiety, 10-14 is moderate anxiety, and 15-21 is severe anxiety.
Time frame: 17 weeks
Investigators will test patients' cognitive performance at the beginning, interim, and conclusion of the study using Mayo Speech Test.
Time frame: 17 weeks
Investigators will test patients' cognitive performance at the beginning, interim, and conclusion of the study using Mayo Test Drive.
Contact information is provided by the study sponsor or research team.
Mayo Clinic
Other
Remote Assessment of Digital Neurologic Testing (RADiaNT)
Acronym: RADiaNT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06952829
Internal Medicine, Neurology
Aulnay-sous-Bois, France
View Trial DetailsNCT07647159
Behavior, Behavioral Symptoms
Moscow, Russia
View Trial DetailsNCT07508670
Brain Diseases, Brain Ischemia
Cork, Ireland
View Trial DetailsNCT06856902
Behavior, Cardiovascular Diseases
Düsseldorf, Germany
View Trial Details